Utility and importance of accurate Hb A2 measurements for defining a strategy for β-Thalassemia screening: Experience in the Balearic Islands, Spain

Hemoglobin

Volumn 37, Issue 6, 2013, Pages 593-598

  López Escribano, Herminio ^a   Parera, Maria M ^a   Guix, Pilar ^a   Castro, José A ^b   Ramon, Misericòrdia ^b   Picornell, Antònia ^b  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^b UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

Thalassemia ( thal); 0 And + thalassemia mutations; Carrier screening; Hb A2

Indexed keywords

HEMOGLOBIN A2; HEMOGLOBIN F;

ARTICLE; BETA THALASSEMIA; ERYTHROCYTE; ERYTHROCYTE PARAMETERS; GENE MUTATION; GENETIC SCREENING; GLOBIN GENE; HETEROZYGOTE; HETEROZYGOTE DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MOLECULAR DIAGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; SPAIN;

ALGORITHMS; ALLELES; BETA-THALASSEMIA; ERYTHROCYTE INDICES; GENOTYPE; HEMOGLOBIN A2; HUMANS; MUTATION; PHENOTYPE; ROC CURVE; SPAIN;

EID: 84887249423     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630269.2013.817337     Document Type: Article

References (18)

1. Giambona A, Passarello C, Renda D, Maggio A. The significance of the Hemoglobin A(2) value in screening for hemoglobinopathies. Clin Biochem. 2009;42(18):1786-1796.
2. Dell'Edera D, Pacella E, Epifania AA, et al. Importance of molecular biology in the characterization of-thalassemia carriers. Eur Rev Med Pharmacol Sci. 2011;15(179-86.
3. Sabath DE, Greisman HA. A multiplex approach to the molecular diagnosis of-thalassemia. J Mol Diagn. 2011;13(4):369-370.
4. Sivalingam M, Looi ML, Zakaria SZ, et al. Molecular study and genotype/phenotype correlation of-thalassaemia in Malaysia. Int J Lab Hematol. 2012;34(4):377-382.
5. Weatherall DJ, Clegg JB. The Thalassaemia Syndromes, 3rd ed. Oxford: Blackwell Scientific, 1981.
6. Kutlar A, Kutlar F, Gu L-G, Mayson SM, Huisman THJ. Fetal hemoglobin in normal adults and-thalassemia heterozygotes. Hum Genet. 1990;85(1106-110.
7. Rund D, Filon D, Strauss N, Rachmilewitz EA, Oppenheim A. Mean corpuscular volume of heterozygotes for-thalassemia correlates with the severity of mutations. Blood. 1992;79(1238-243.
8. Stefanis L, Kanavakis E, Traeger-Synodinos J, Tzetis M, Metaxotou-Mavromati A, Kattamis C. Hematologic phenotype of the mutations IVS1-n6 (T!C), IVS1-n110 (G!A), and CD39 (C!T) in carriers of-thalassemia in Greece. Pediatr Hematol Oncol. 1994;11(5):509-517.
9. Bragós IM, Noguera NI, Raviola MA,Milani C. Gené ticamolecular de talasémicos heterocigotos. Interrelación con parámetros hematológicos. Rev Cubana Hematol Inmunol Hemoter.2005;21(11-11.
10. MamtaniM, Jawahirani A, Rughwani V, das K, Kulkarni H. Value ofmean corpuscular volume andmean corpuscular haemoglobin in screening of-thalassemia trait. Acta Haematol. 2006;116(3):223-225.
11. Khattak SA, Ahmed S, Anwar J, Ali N, Shaikh KH. Prevalence of various mutations in thalassaemia and its association with haematological parameters. J Pak Med Assoc. 2012;62(140-43.
12. Atanasovska B, Bozhinovski G, Chakalova L, Kocheva S, Karanfilski O, Plaseska-Karanfilska D. Molecular diagnostics of-thalassemia. BJMG. 2012;15(Suppl):61-65.
13. Old JM. Screening and genetic diagnosis of haemoglobinopathies. Scand J Clin Lab Invest. 2007;67 (171-86.
14. López-Escribano H, Parera M, Guix P, et al. Balearic archipelago: three islands, three-thalassemia population patterns. Clin Genet. 2013;83(2):175-180.
15. Moreno I, Bolufer P, Perez ML, Barragán E, Sanz MA. Rapid detection of the major Mediterranean-thalassaemia mutations by real-time polymerase chain reaction using fluorophore-labelled hybridization probes. Br J Haematol. 2002;119(2):554-557.
16. Clark BE, Thein SL. Molecular diagnosis of haemoglobin disorders. Clin Lab Haematol. 2004;26 (3):159-176.
17. Vrettou C, Kanavakis E, Traeger-Synodinos J, et al. Molecular studies of-thalassemia heterozygotes with raised Hb F levels. Hemoglobin. 2000;24(3):203-220.
18. Mosca A, Paleari R, Ivaldi G, Galanello R, Giordano PC. The role of Haemoglobin A(2) testing in the diagnosis of thalassaemias and haemoglobinopathies. J Clin Pathol 2009;62(113-17.